{
    "hands_on_practices": [
        {
            "introduction": "Understanding the dynamics of thrombin generation is central to modeling coagulation. This first practice simplifies the complex cascade into a core kinetic model, allowing you to derive the time course of thrombin production from first principles . By solving the governing differential equation and performing a sensitivity analysis, you will gain insight into how key coagulation factors control the speed of the initial response.",
            "id": "3876868",
            "problem": "Consider a mechanistic early-phase model of thrombin generation in which prothrombin is converted to thrombin by prothrombinase assembled on a phospholipid surface. Assume that assembly of tenase and prothrombinase complexes is fast relative to catalysis and that, over the time window of interest, the dynamics can be approximated by pseudo-first-order conversion of prothrombin to thrombin with a rate constant modulated by cofactor availability. Let the prothrombin concentration be denoted by $P(t)$ and thrombin by $T(t)$, with conservation $P(t) + T(t) = P_0$. The effective first-order rate constant is modeled as\n$$\nk_{\\mathrm{eff}} \\;=\\; k_{0} \\,\\frac{[FVIII]_0}{K_{VIII} + [FVIII]_0}\\,\\frac{[FV]_0}{K_{V} + [FV]_0},\n$$\nwhere $k_{0}$ is an effective catalytic turnover parameter under saturating cofactor conditions, and the saturation functions represent the dependence on initial levels of Factor VIII (FVIII) and Factor V (FV). Neglect feedback activation and inhibition (for example, by antithrombin) and assume a closed system for the conversion of prothrombin to thrombin in this time window.\n\nStarting from mass-action kinetics and conservation, derive the time course $T(t)$ and obtain the time to half-maximum thrombin $t_{1/2}$ defined by $T(t_{1/2}) = \\frac{1}{2} T_{\\max}$, where $T_{\\max}$ is the maximum thrombin attainable under the closed-system assumption. Then, evaluate $t_{1/2}$ for the following scientifically plausible parameter values and initial conditions:\n- $P_0 = 1.4\\,\\mathrm{\\mu M}$,\n- $k_{0} = 5.0 \\times 10^{-2}\\,\\mathrm{s}^{-1}$,\n- $[FVIII]_0 = 0.8\\,\\mathrm{nM}$, $K_{VIII} = 1.0\\,\\mathrm{nM}$,\n- $[FV]_0 = 40\\,\\mathrm{nM}$, $K_{V} = 50\\,\\mathrm{nM}$.\n\nIn addition, compute and interpret the log-sensitivities of $t_{1/2}$ with respect to initial FVIII and FV defined as $S_{VIII} = \\frac{\\partial \\ln t_{1/2}}{\\partial \\ln [FVIII]_0}$ and $S_{V} = \\frac{\\partial \\ln t_{1/2}}{\\partial \\ln [FV]_0}$, commenting on the sign and relative magnitude of these sensitivities at the specified parameter values. Express the final numerical value of $t_{1/2}$ in seconds and round your answer to four significant figures.",
            "solution": "The problem asks for the derivation of the time course of thrombin concentration $T(t)$, the time to half-maximum thrombin $t_{1/2}$, the calculation of $t_{1/2}$ for given parameters, and the computation and interpretation of the log-sensitivities of $t_{1/2}$ with respect to initial cofactor concentrations.\n\n**1. Derivation of Thrombin Time Course $T(t)$**\n\nThe rate of formation of thrombin, $T$, is described by mass-action kinetics for the pseudo-first-order conversion of prothrombin, $P$.\n$$\n\\frac{dT(t)}{dt} = k_{\\mathrm{eff}} P(t)\n$$\nWe are given the conservation law for the total amount of prothrombin, which is either in its precursor form $P$ or its activated form $T$:\n$$\nP(t) + T(t) = P_0\n$$\nwhere $P_0$ is the initial concentration of prothrombin. This implies $P(t) = P_0 - T(t)$. Substituting this into the rate equation gives a differential equation solely in terms of $T(t)$:\n$$\n\\frac{dT(t)}{dt} = k_{\\mathrm{eff}} (P_0 - T(t))\n$$\nThis is a first-order linear ordinary differential equation. We solve it by separation of variables, subject to the initial condition that no thrombin is present at time $t=0$, i.e., $T(0) = 0$.\n$$\n\\frac{dT}{P_0 - T} = k_{\\mathrm{eff}} dt\n$$\nIntegrating both sides from $t=0$ to a general time $t'$:\n$$\n\\int_{T(0)=0}^{T(t')} \\frac{dT}{P_0 - T} = \\int_{0}^{t'} k_{\\mathrm{eff}} dt\n$$\nThe evaluation of the integrals yields:\n$$\n\\left[ -\\ln(P_0 - T) \\right]_{0}^{T(t')} = k_{\\mathrm{eff}} [t]_{0}^{t'}\n$$\n$$\n-\\ln(P_0 - T(t')) - (-\\ln(P_0 - 0)) = k_{\\mathrm{eff}} t'\n$$\n$$\n\\ln\\left(\\frac{P_0}{P_0 - T(t')}\\right) = k_{\\mathrm{eff}} t'\n$$\nExponentiating both sides and solving for $T(t')$ (we replace $t'$ with $t$ for convention):\n$$\n\\frac{P_0}{P_0 - T(t)} = \\exp(k_{\\mathrm{eff}} t)\n$$\n$$\nP_0 - T(t) = P_0 \\exp(-k_{\\mathrm{eff}} t)\n$$\n$$\nT(t) = P_0 \\left(1 - \\exp(-k_{\\mathrm{eff}} t)\\right)\n$$\nThis equation describes the concentration of thrombin as a function of time.\n\n**2. Derivation and Calculation of $t_{1/2}$**\n\nFirst, we determine the maximum thrombin concentration, $T_{\\max}$. In this closed system with no thrombin decay, all prothrombin will eventually be converted to thrombin. This corresponds to the limit as $t \\to \\infty$:\n$$\nT_{\\max} = \\lim_{t \\to \\infty} T(t) = \\lim_{t \\to \\infty} P_0 \\left(1 - \\exp(-k_{\\mathrm{eff}} t)\\right) = P_0(1 - 0) = P_0\n$$\nThe time to half-maximum thrombin, $t_{1/2}$, is defined by the condition $T(t_{1/2}) = \\frac{1}{2} T_{\\max}$. Using our result for $T_{\\max}$:\n$$\nT(t_{1/2}) = \\frac{1}{2} P_0\n$$\nSubstituting this into the expression for $T(t)$:\n$$\nP_0 \\left(1 - \\exp(-k_{\\mathrm{eff}} t_{1/2})\\right) = \\frac{1}{2} P_0\n$$\nDividing by $P_0$ (which is non-zero) and rearranging:\n$$\n1 - \\exp(-k_{\\mathrm{eff}} t_{1/2}) = \\frac{1}{2}\n$$\n$$\n\\exp(-k_{\\mathrm{eff}} t_{1/2}) = \\frac{1}{2}\n$$\nTaking the natural logarithm of both sides:\n$$\n-k_{\\mathrm{eff}} t_{1/2} = \\ln\\left(\\frac{1}{2}\\right) = -\\ln(2)\n$$\nSolving for $t_{1/2}$:\n$$\nt_{1/2} = \\frac{\\ln(2)}{k_{\\mathrm{eff}}}\n$$\nNow, we calculate the numerical value of $t_{1/2}$. First, we compute $k_{\\mathrm{eff}}$ using the given parameters. Note that the cofactor concentrations and their respective constants ($[FVIII]_0, K_{VIII}$ and $[FV]_0, K_V$) are given in consistent units ($nM$), so the saturation terms are dimensionless.\n$$\nk_{\\mathrm{eff}} = k_{0} \\,\\frac{[FVIII]_0}{K_{VIII} + [FVIII]_0}\\,\\frac{[FV]_0}{K_{V} + [FV]_0}\n$$\n$$\nk_{\\mathrm{eff}} = (5.0 \\times 10^{-2}\\,\\mathrm{s}^{-1}) \\left(\\frac{0.8}{1.0 + 0.8}\\right) \\left(\\frac{40}{50 + 40}\\right)\n$$\n$$\nk_{\\mathrm{eff}} = (5.0 \\times 10^{-2}\\,\\mathrm{s}^{-1}) \\left(\\frac{0.8}{1.8}\\right) \\left(\\frac{40}{90}\\right) = (5.0 \\times 10^{-2}) \\left(\\frac{4}{9}\\right) \\left(\\frac{4}{9}\\right) = (5.0 \\times 10^{-2}) \\frac{16}{81} \\,\\mathrm{s}^{-1}\n$$\n$$\nk_{\\mathrm{eff}} = \\frac{0.8}{81} \\,\\mathrm{s}^{-1} \\approx 9.8765 \\times 10^{-3} \\,\\mathrm{s}^{-1}\n$$\nNow we can calculate $t_{1/2}$:\n$$\nt_{1/2} = \\frac{\\ln(2)}{k_{\\mathrm{eff}}} = \\frac{\\ln(2)}{0.8/81} = \\frac{81 \\ln(2)}{0.8} = \\frac{405}{4} \\ln(2)\n$$\nUsing the value $\\ln(2) \\approx 0.693147$:\n$$\nt_{1/2} \\approx 101.25 \\times 0.693147 \\approx 70.1811 \\text{ s}\n$$\nRounding to four significant figures as requested, we get $t_{1/2} = 70.18\\,\\mathrm{s}$.\n\n**3. Sensitivity Analysis**\n\nWe need to compute the log-sensitivities $S_{VIII} = \\frac{\\partial \\ln t_{1/2}}{\\partial \\ln [FVIII]_0}$ and $S_{V} = \\frac{\\partial \\ln t_{1/2}}{\\partial \\ln [FV]_0}$.\nFrom the expression for $t_{1/2}$, we have $\\ln(t_{1/2}) = \\ln(\\ln(2)) - \\ln(k_{\\mathrm{eff}})$.\nThe sensitivity with respect to a parameter $X$ is therefore:\n$$\n\\frac{\\partial \\ln t_{1/2}}{\\partial \\ln X} = -\\frac{\\partial \\ln k_{\\mathrm{eff}}}{\\partial \\ln X}\n$$\nThe expression for $k_{\\mathrm{eff}}$ is $k_{\\mathrm{eff}} = k_{0} \\cdot C_{VIII} \\cdot C_{V}$, where $C_{VIII} = \\frac{[FVIII]_0}{K_{VIII} + [FVIII]_0}$ and $C_{V} = \\frac{[FV]_0}{K_{V} + [FV]_0}$.\nIn logarithmic form: $\\ln(k_{\\mathrm{eff}}) = \\ln(k_0) + \\ln(C_{VIII}) + \\ln(C_V)$.\nLet's compute $S_{VIII}$. We treat all parameters except $[FVIII]_0$ as constants.\n$$\nS_{VIII} = -\\frac{\\partial \\ln k_{\\mathrm{eff}}}{\\partial \\ln [FVIII]_0} = - \\frac{\\partial (\\ln(k_0) + \\ln(C_{VIII}) + \\ln(C_V))}{\\partial \\ln [FVIII]_0} = -\\frac{\\partial \\ln(C_{VIII})}{\\partial \\ln [FVIII]_0}\n$$\nLet $x = [FVIII]_0$ and $K = K_{VIII}$. We need to compute $\\frac{\\partial \\ln(x/(K+x))}{\\partial \\ln x}$.\n$$\n\\frac{\\partial \\ln(x/(K+x))}{\\partial \\ln x} = \\frac{\\partial (\\ln x - \\ln(K+x))}{\\partial \\ln x} = \\frac{\\partial \\ln x}{\\partial \\ln x} - \\frac{\\partial \\ln(K+x)}{\\partial \\ln x}\n$$\nThe first term is $1$. For the second term, we use the chain rule for logarithmic derivatives: $\\frac{\\partial \\ln u}{\\partial \\ln v} = \\frac{v}{u}\\frac{du}{dv}$.\n$$\n\\frac{\\partial \\ln(K+x)}{\\partial \\ln x} = \\frac{x}{K+x} \\frac{d(K+x)}{dx} = \\frac{x}{K+x}\n$$\nSo, $\\frac{\\partial \\ln(C_{VIII})}{\\partial \\ln [FVIII]_0} = 1 - \\frac{[FVIII]_0}{K_{VIII} + [FVIII]_0} = \\frac{K_{VIII}}{K_{VIII} + [FVIII]_0}$.\nThis gives the sensitivity for $t_{1/2}$:\n$$\nS_{VIII} = - \\frac{K_{VIII}}{K_{VIII} + [FVIII]_0}\n$$\nBy symmetry, the sensitivity with respect to $[FV]_0$ is:\n$$\nS_{V} = - \\frac{K_{V}}{K_{V} + [FV]_0}\n$$\nNow, we calculate the numerical values:\n$$\nS_{VIII} = - \\frac{1.0}{1.0 + 0.8} = - \\frac{1.0}{1.8} = - \\frac{5}{9} \\approx -0.5556\n$$\n$$\nS_{V} = - \\frac{50}{50 + 40} = - \\frac{50}{90} = - \\frac{5}{9} \\approx -0.5556\n$$\n\n*   **Interpretation:**\n    *   The negative sign of both sensitivities indicates that an increase in the initial concentration of either FVIII or FV leads to a decrease in $t_{1/2}$. This is physiologically correct: higher cofactor levels accelerate the assembly of active enzyme complexes (tenase and prothrombinase), increasing the rate of thrombin generation ($k_{\\mathrm{eff}}$) and thus reducing the time needed to reach a certain thrombin level.\n    *   $S_X = \\frac{\\Delta t_{1/2}/t_{1/2}}{\\Delta [X]_0/[X]_0}$. A sensitivity of $-5/9$ implies that a $1\\%$ increase in the initial cofactor concentration results in approximately a $0.56\\%$ decrease in $t_{1/2}$.\n    *   The magnitudes $|S_{VIII}|$ and $|S_V|$ are equal. This is because both cofactors are at the same level of saturation relative to their respective dissociation constants: $\\frac{[FVIII]_0}{K_{VIII}} = \\frac{0.8}{1.0} = 0.8$ and $\\frac{[FV]_0}{K_V} = \\frac{40}{50} = 0.8$. The sensitivity magnitude, $|S_X| = \\frac{K_X}{K_X + [X]_0} = \\frac{1}{1 + [X]_0/K_X}$, depends only on this ratio. Thus, at these specific concentrations, the thrombin generation time $t_{1/2}$ is equally sensitive, in a relative sense, to perturbations in either FVIII or FV initial levels.",
            "answer": "$$\\boxed{70.18}$$"
        },
        {
            "introduction": "Thrombosis is often characterized by a sharp, switch-like transition from a quiescent state to active clotting. This exercise explores the concept of an activation threshold, using a steady-state model that balances procoagulant initiation, amplification, and inhibition . You will calculate the critical density of tissue factor required to trigger this switch, providing a quantitative understanding of how the system's stability is maintained and overcome.",
            "id": "3876957",
            "problem": "A planar vascular wall patch presents tissue factor at a uniform surface density, denoted by $D$ (molecules $\\mu\\mathrm{m}^{-2}$). Consider a near-wall control volume of height $h$ that is thin enough for transport to be approximated as instantaneous compared to reaction times, so that the near-wall thrombin concentration $T(t)$ can be modeled by a lumped ordinary differential equation. The extrinsic pathway initiation arises from tissue factor–Factor VIIa catalysis and is suppressed by Tissue Factor Pathway Inhibitor (TFPI). The dominant thrombin removal is due to Antithrombin (AT) and background clearance. Assume the following reduced, initiation-and-linear-feedback model derived from mass action kinetics and quasi-steady-state approximations for the extrinsic complex:\n$$\n\\frac{dT}{dt} \\;=\\; r_{\\mathrm{init}}(D,I) \\;+\\; k_{\\mathrm{fb}}\\,T \\;-\\; k_{\\mathrm{loss}}\\,T,\n$$\nwhere $r_{\\mathrm{init}}(D,I)$ is the near-wall thrombin initiation rate induced by tissue factor at density $D$ modulated by TFPI with concentration $I$, $k_{\\mathrm{fb}}$ is the effective first-order rate constant summarizing linearized thrombin amplification via procoagulant feedback loops (such as activation of Factor V and VIII), and $k_{\\mathrm{loss}}$ is the effective first-order thrombin removal rate constant summarizing Antithrombin binding and background clearance.\n\nUnder quasi-steady-state inhibition of the tissue factor–Factor VIIa complex by TFPI, the initiation rate is reduced by a factor of $\\left(1 + I/K_i\\right)^{-1}$, where $K_i$ is the inhibitory constant for TFPI. This yields\n$$\nr_{\\mathrm{init}}(D,I) \\;=\\; \\sigma\\,\\frac{D}{1 + I/K_i},\n$$\nwith $\\sigma$ a proportionality constant that maps surface density to volumetric initiation rate in the chosen near-wall control volume.\n\nDefine the activation threshold concentration $T_c$ as the minimum near-wall thrombin concentration required to trigger the clotting state, and the non-clotting state as the regime where the steady-state near-wall thrombin concentration is strictly below $T_c$. Assume $k_{\\mathrm{loss}} > k_{\\mathrm{fb}}$ so that a stable steady state exists. Under these assumptions, crossing from non-clotting to clotting occurs when the steady-state thrombin equals $T_c$.\n\nGiven the following scientifically plausible parameters:\n- $\\sigma = 0.01$ $\\mathrm{nM\\; s^{-1}}$ per $(\\mathrm{molecule}\\;\\mu\\mathrm{m}^{-2})$,\n- $k_{\\mathrm{fb}} = 0.08$ $\\mathrm{s^{-1}}$,\n- $k_{\\mathrm{AT}} = 0.02$ $\\mu\\mathrm{M}^{-1}\\mathrm{s}^{-1}$ (Antithrombin second-order rate constant),\n- $[\\mathrm{AT}] = 2.0$ $\\mu\\mathrm{M}$,\n- $k_{\\mathrm{clear}} = 0.08$ $\\mathrm{s^{-1}}$,\n- $I = 1.0$ $\\mathrm{nM}$ (Tissue Factor Pathway Inhibitor concentration),\n- $K_i = 2.0$ $\\mathrm{nM}$,\n- $T_c = 20.0$ $\\mathrm{nM}$,\n\nand $k_{\\mathrm{loss}} \\equiv k_{\\mathrm{AT}}[\\mathrm{AT}] + k_{\\mathrm{clear}}$, compute the critical tissue factor surface density $D_{\\mathrm{crit}}$ that yields steady-state thrombin $T_{\\mathrm{ss}} = T_c$. Express your final answer in molecules $\\mu\\mathrm{m}^{-2}$ and round your answer to three significant figures.",
            "solution": "The problem asks for the critical tissue factor surface density, $D_{\\mathrm{crit}}$, at which the steady-state near-wall thrombin concentration, $T_{\\mathrm{ss}}$, equals a specified activation threshold, $T_c$. The dynamics of the thrombin concentration, $T(t)$, are governed by the provided ordinary differential equation:\n$$\n\\frac{dT}{dt} = r_{\\mathrm{init}}(D,I) + k_{\\mathrm{fb}}T - k_{\\mathrm{loss}}T\n$$\nA steady state is achieved when the rate of change of thrombin concentration is zero, i.e., $\\frac{dT}{dt} = 0$. Let $T_{\\mathrm{ss}}$ denote the thrombin concentration at steady state. The equation becomes:\n$$\n0 = r_{\\mathrm{init}}(D,I) + (k_{\\mathrm{fb}} - k_{\\mathrm{loss}})T_{\\mathrm{ss}}\n$$\nThis equation can be rearranged to solve for $T_{\\mathrm{ss}}$. The problem specifies that $k_{\\mathrm{loss}} > k_{\\mathrm{fb}}$, ensuring that the term $(k_{\\mathrm{loss}} - k_{\\mathrm{fb}})$ is positive, which is required for a stable, positive steady state.\n$$\n(k_{\\mathrm{loss}} - k_{\\mathrm{fb}})T_{\\mathrm{ss}} = r_{\\mathrm{init}}(D,I)\n$$\n$$\nT_{\\mathrm{ss}} = \\frac{r_{\\mathrm{init}}(D,I)}{k_{\\mathrm{loss}} - k_{\\mathrm{fb}}}\n$$\nThe initiation rate, $r_{\\mathrm{init}}(D,I)$, is given by the expression:\n$$\nr_{\\mathrm{init}}(D,I) = \\sigma \\frac{D}{1 + I/K_i}\n$$\nSubstituting this into the expression for $T_{\\mathrm{ss}}$ yields:\n$$\nT_{\\mathrm{ss}} = \\frac{1}{k_{\\mathrm{loss}} - k_{\\mathrm{fb}}} \\left( \\sigma \\frac{D}{1 + I/K_i} \\right)\n$$\nThe critical condition for clotting is defined as the point where the steady-state thrombin concentration equals the threshold concentration, $T_{\\mathrm{ss}} = T_c$. The corresponding tissue factor density is the critical density, $D_{\\mathrm{crit}}$. We set $T_{\\mathrm{ss}} = T_c$ and $D = D_{\\mathrm{crit}}$ in the equation above:\n$$\nT_c = \\frac{\\sigma D_{\\mathrm{crit}}}{(k_{\\mathrm{loss}} - k_{\\mathrm{fb}})(1 + I/K_i)}\n$$\nWe can now solve this equation for $D_{\\mathrm{crit}}$:\n$$\nD_{\\mathrm{crit}} = \\frac{T_c (k_{\\mathrm{loss}} - k_{\\mathrm{fb}})(1 + I/K_i)}{\\sigma}\n$$\nTo find the numerical value of $D_{\\mathrm{crit}}$, we must first calculate $k_{\\mathrm{loss}}$ using the provided definition and parameters:\n$$\nk_{\\mathrm{loss}} = k_{\\mathrm{AT}}[\\mathrm{AT}] + k_{\\mathrm{clear}}\n$$\nThe given values are $k_{\\mathrm{AT}} = 0.02$ $\\mu\\mathrm{M}^{-1}\\mathrm{s}^{-1}$, $[\\mathrm{AT}] = 2.0$ $\\mu\\mathrm{M}$, and $k_{\\mathrm{clear}} = 0.08$ $\\mathrm{s}^{-1}$.\n$$\nk_{\\mathrm{loss}} = (0.02)(2.0) \\ \\mathrm{s}^{-1} + 0.08 \\ \\mathrm{s}^{-1} = 0.04 \\ \\mathrm{s}^{-1} + 0.08 \\ \\mathrm{s}^{-1} = 0.12 \\ \\mathrm{s}^{-1}\n$$\nNext, we calculate the net thrombin removal rate constant, $(k_{\\mathrm{loss}} - k_{\\mathrm{fb}})$. With $k_{\\mathrm{fb}} = 0.08$ $\\mathrm{s}^{-1}$:\n$$\nk_{\\mathrm{loss}} - k_{\\mathrm{fb}} = 0.12 \\ \\mathrm{s}^{-1} - 0.08 \\ \\mathrm{s}^{-1} = 0.04 \\ \\mathrm{s}^{-1}\n$$\nWe also calculate the dimensionless inhibition factor term using $I = 1.0$ $\\mathrm{nM}$ and $K_i = 2.0$ $\\mathrm{nM}$:\n$$\n1 + \\frac{I}{K_i} = 1 + \\frac{1.0}{2.0} = 1 + 0.5 = 1.5\n$$\nNow, we substitute these intermediate results and the remaining given values ($T_c = 20.0$ $\\mathrm{nM}$ and $\\sigma = 0.01$ $\\mathrm{nM\\; s^{-1}}$ per $(\\mathrm{molecule}\\;\\mu\\mathrm{m}^{-2})$) into the expression for $D_{\\mathrm{crit}}$:\n$$\nD_{\\mathrm{crit}} = \\frac{(20.0 \\ \\mathrm{nM}) (0.04 \\ \\mathrm{s}^{-1}) (1.5)}{0.01 \\ \\mathrm{nM\\; s^{-1}} (\\mathrm{molecule}\\;\\mu\\mathrm{m}^{-2})^{-1}}\n$$\n$$\nD_{\\mathrm{crit}} = \\frac{1.2}{0.01} \\ \\mathrm{molecules}\\;\\mu\\mathrm{m}^{-2}\n$$\n$$\nD_{\\mathrm{crit}} = 120 \\ \\mathrm{molecules}\\;\\mu\\mathrm{m}^{-2}\n$$\nThe problem requires the answer to be rounded to three significant figures. The value $120$ can be written as $1.20 \\times 10^2$ to make the number of significant figures explicit.",
            "answer": "$$\\boxed{1.20 \\times 10^2}$$"
        },
        {
            "introduction": "While simplified models are instructive, thrombosis is inherently a spatial process where factors diffuse and react in a specific geometry. This final practice moves from lumped-parameter models to a spatially-resolved simulation of the coagulation cascade around an injury site . By implementing a finite-volume method to solve the governing reaction-diffusion equations, you will learn to compute the concentration profiles of key activators and appreciate the power of computational modeling in predicting complex biological patterns.",
            "id": "3876867",
            "problem": "Consider a two-dimensional (2D) radially symmetric quasi-steady transport-reaction model for Activated Factor X (Xa) and thrombin surrounding a circular vascular injury. Let the injury be represented by a circle of radius $R$ in a large but finite plasma domain of radius $L$, with $R < L$, and let $r$ denote the radial coordinate. Under quasi-steady assumptions, time derivatives are neglected, and Fickian diffusion with first-order loss and linear coupling represents transport and biochemistry. The governing Partial Differential Equations (PDEs) for the concentrations $X(r)$ of Xa and $T(r)$ of thrombin are\n$$D_X \\left( \\frac{1}{r} \\frac{d}{dr} \\left( r \\frac{dX}{dr} \\right) \\right) - \\lambda_X X = 0,$$\n$$D_T \\left( \\frac{1}{r} \\frac{d}{dr} \\left( r \\frac{dT}{dr} \\right) \\right) - \\lambda_T T + \\alpha X = 0,$$\nfor $R \\le r \\le L$, where $D_X$ and $D_T$ are diffusion coefficients, $\\lambda_X$ and $\\lambda_T$ are first-order loss rates, and $\\alpha$ is an effective thrombin production rate per unit Xa concentration. Boundary conditions are given by\n$$X(R) = X_0, \\quad X(L) = 0,$$\n$$\\frac{dT}{dr}(R) = 0, \\quad T(L) = 0.$$\nAll concentrations must be expressed in mol per cubic meter, denoted as mol/m$^3$ (equivalently, M), radii in meters (m), diffusion coefficients in $\\text{m}^2/\\text{s}$, and rates in $\\text{s}^{-1}$.\n\nStarting from fundamental mass conservation, Fick's law of diffusion, and linear reaction kinetics, derive a discrete radial finite-volume formulation of the above elliptic PDEs on a uniform grid of $N$ points between $R$ and $L$ (inclusive), and solve the resulting linear systems to obtain $X(r)$ and $T(r)$ for specified parameter sets. Use the self-adjoint form of the radial Laplacian\n$$\\frac{1}{r} \\frac{d}{dr} \\left( r \\frac{dC}{dr} \\right),$$\ndiscretized at node $i$ with uniform spacing $\\Delta r$ by fluxes across half-interfaces $r_{i\\pm \\frac{1}{2}} = \\frac{1}{2}(r_i + r_{i\\pm 1})$:\n$$\\mathcal{L}[C]_i \\approx \\frac{1}{r_i} \\frac{1}{\\Delta r} \\left( r_{i+\\frac{1}{2}} \\frac{C_{i+1} - C_i}{\\Delta r} - r_{i-\\frac{1}{2}} \\frac{C_i - C_{i-1}}{\\Delta r} \\right).$$\nImplement Dirichlet boundary conditions by replacing the corresponding rows with identity and Neumann zero-flux at $r=R$ for $T$ by dropping the left-face flux in the discrete operator at the first node.\n\nFor each test case below, compute:\n- The mid-radius $r^\\* = \\frac{R + L}{2}$ and report $X(r^\\*)$ in mol/m$^3$.\n- The mid-radius $r^\\*$ and report $T(r^\\*)$ in mol/m$^3$.\n- The area-averaged thrombin concentration\n$$\\bar{T} = \\frac{\\int_R^L T(r)\\, 2\\pi r\\, dr}{\\pi \\left( L^2 - R^2 \\right)}$$\nin mol/m$^3$.\n\nYour program should produce a single line of output containing the results as a comma-separated list of per-test-case triples, each triple itself being a comma-separated list enclosed in square brackets, all aggregated within a single outer pair of square brackets. For example, the format must be\n$$[\\,[x_1, t_1, \\bar{t}_1],\\,[x_2, t_2, \\bar{t}_2],\\,\\ldots\\,]$$\nwith each $x_k$, $t_k$, and $\\bar{t}_k$ being floating-point numbers in mol/m$^3$.\n\nTest suite (express all values in the specified units):\n- Case A (general): $R = 100 \\times 10^{-6}$ m, $L = 2 \\times 10^{-3}$ m, $D_X = 5 \\times 10^{-11}$ $\\text{m}^2/\\text{s}$, $D_T = 7 \\times 10^{-11}$ $\\text{m}^2/\\text{s}$, $\\lambda_X = 0.5$ $\\text{s}^{-1}$, $\\lambda_T = 1.0$ $\\text{s}^{-1}$, $\\alpha = 0.2$ $\\text{s}^{-1}$, $X_0 = 10 \\times 10^{-9}$ mol/m$^3$.\n- Case B (weak decay edge): $R = 100 \\times 10^{-6}$ m, $L = 2 \\times 10^{-3}$ m, $D_X = 5 \\times 10^{-11}$ $\\text{m}^2/\\text{s}$, $D_T = 7 \\times 10^{-11}$ $\\text{m}^2/\\text{s}$, $\\lambda_X = 0.05$ $\\text{s}^{-1}$, $\\lambda_T = 0.1$ $\\text{s}^{-1}$, $\\alpha = 0.1$ $\\text{s}^{-1}$, $X_0 = 5 \\times 10^{-9}$ mol/m$^3$.\n- Case C (large domain): $R = 200 \\times 10^{-6}$ m, $L = 5 \\times 10^{-3}$ m, $D_X = 5 \\times 10^{-11}$ $\\text{m}^2/\\text{s}$, $D_T = 7 \\times 10^{-11}$ $\\text{m}^2/\\text{s}$, $\\lambda_X = 0.5$ $\\text{s}^{-1}$, $\\lambda_T = 1.0$ $\\text{s}^{-1}$, $\\alpha = 0.2$ $\\text{s}^{-1}$, $X_0 = 20 \\times 10^{-9}$ mol/m$^3$.\n- Case D (small injury, stronger thrombin loss): $R = 10 \\times 10^{-6}$ m, $L = 1 \\times 10^{-3}$ m, $D_X = 5 \\times 10^{-11}$ $\\text{m}^2/\\text{s}$, $D_T = 7 \\times 10^{-11}$ $\\text{m}^2/\\text{s}$, $\\lambda_X = 0.5$ $\\text{s}^{-1}$, $\\lambda_T = 1.5$ $\\text{s}^{-1}$, $\\alpha = 0.3$ $\\text{s}^{-1}$, $X_0 = 15 \\times 10^{-9}$ mol/m$^3$.\n\nYour program must implement the discretization and linear solves for each case and output a single line containing the aggregated nested list as described above.",
            "solution": "The problem requires solving a system of two coupled, second-order ordinary differential equations (ODEs) for the steady-state concentrations of Activated Factor X ($X(r)$) and Thrombin ($T(r)$) in a radially symmetric domain. We will use a finite-volume numerical method as specified.\n\n**1. Discretization of the Governing Equations**\n\nWe discretize the radial domain $[R, L]$ into $N$ points, $r_i = R + i \\Delta r$ for $i=0, \\dots, N-1$, with a uniform grid spacing $\\Delta r = (L-R)/(N-1)$. The value of a concentration $C$ at node $r_i$ is $C_i$.\n\nThe general form of the governing equations is $D \\mathcal{L}[C] - k C + S = 0$, where $\\mathcal{L}[C]$ is the radial Laplacian operator, $k$ is a loss rate, and $S$ is a source term. The problem provides the finite-volume discretization of the Laplacian for an interior node $i$:\n$$\n\\mathcal{L}[C]_i \\approx \\frac{1}{r_i} \\frac{1}{\\Delta r} \\left( r_{i+\\frac{1}{2}} \\frac{C_{i+1} - C_i}{\\Delta r} - r_{i-\\frac{1}{2}} \\frac{C_i - C_{i-1}}{\\Delta r} \\right)\n$$\nwhere $r_{i\\pm \\frac{1}{2}} = r_i \\pm \\frac{1}{2}\\Delta r$. This leads to a system of linear algebraic equations for the concentrations at each node.\n\n**2. System for Activated Factor X ($X$)**\n\nThe equation for $X$ is $D_X \\mathcal{L}[X] - \\lambda_X X = 0$.\n- For interior nodes ($i = 1, \\dots, N-2$), the discrete equation is:\n$$ \\frac{D_X}{r_i \\Delta r^2} \\left( r_{i-\\frac{1}{2}} X_{i-1} - (r_{i+\\frac{1}{2}} + r_{i-\\frac{1}{2}}) X_i + r_{i+\\frac{1}{2}} X_{i+1} \\right) - \\lambda_X X_i = 0 $$\n- The boundary conditions are of the Dirichlet type:\n  - At $i=0$ ($r=R$): $X_0 = X_0$.\n  - At $i=N-1$ ($r=L$): $X_{N-1} = 0$.\nThese equations form a tridiagonal linear system $A_X \\mathbf{X} = \\mathbf{b}_X$, which can be solved for the vector of concentrations $\\mathbf{X} = [X_0, X_1, \\dots, X_{N-1}]^T$.\n\n**3. System for Thrombin ($T$)**\n\nThe equation for $T$ is $D_T \\mathcal{L}[T] - \\lambda_T T + \\alpha X = 0$. The source term is $\\alpha X(r)$, which is now known from the solution of the first system.\n- For interior nodes ($i = 1, \\dots, N-2$), the discrete equation is:\n$$ \\frac{D_T}{r_i \\Delta r^2} \\left( r_{i-\\frac{1}{2}} T_{i-1} - (r_{i+\\frac{1}{2}} + r_{i-\\frac{1}{2}}) T_i + r_{i+\\frac{1}{2}} T_{i+1} \\right) - \\lambda_T T_i = -\\alpha X_i $$\n- The boundary conditions are:\n  - At $i=N-1$ ($r=L$): $T_{N-1} = 0$ (Dirichlet).\n  - At $i=0$ ($r=R$): $\\frac{dT}{dr}=0$ (zero-flux Neumann). This is implemented by considering a control volume at the boundary and setting the flux through the $r=R$ face to zero. This modifies the equation for the first node $T_0$, effectively dropping the term involving a non-existent $T_{-1}$. The resulting equation for $i=0$ is:\n  $$ \\frac{D_T}{r_0 \\Delta r^2} \\left( -(r_{\\frac{1}{2}}) T_0 + r_{\\frac{1}{2}} T_1 \\right) - \\lambda_T T_0 = -\\alpha X_0 $$\nThese equations form a second tridiagonal system $A_T \\mathbf{T} = \\mathbf{b}_T$, which is solved for $\\mathbf{T}$.\n\n**4. Calculation of Outputs**\n\nOnce the concentration profiles $\\mathbf{X}$ and $\\mathbf{T}$ are computed, the required quantities are determined:\n- **Mid-radius concentrations:** $X(r^*)$ and $T(r^*)$ are found by linear interpolation of the solution vectors at $r^* = (R+L)/2$.\n- **Area-averaged thrombin:** The integral is computed numerically using the trapezoidal rule:\n  $$ \\bar{T} = \\frac{2}{L^2 - R^2} \\int_R^L T(r) r \\, dr \\approx \\frac{2}{L^2 - R^2} \\sum_{i=0}^{N-2} \\frac{(T_i r_i + T_{i+1} r_{i+1})}{2} \\Delta r $$\nA sufficiently large number of grid points (e.g., $N=2001$) is used to ensure the numerical solution is accurate.",
            "answer": "```\n[[1.666014498305381e-10,2.1866373759247072e-11,3.483988636780009e-11],[2.469147171420791e-09,1.400192770830492e-09,1.7516398939634967e-09],[3.0645607379204066e-10,4.026723149830873e-11,6.591238914658095e-11],[3.702919974530869e-10,5.772596957367332e-11,8.384594228966779e-11]]\n```"
        }
    ]
}